Home    Back

Inactivated trivalent influenza vaccine    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
63Idiopathic thrombocytopenic purpura1

63. Idiopathic thrombocytopenic purpura    [ 311 clinical trials,   185 drugs,   (DrugBank: 39 drugs),   43 drug target genes,   132 drug target pathways]
Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 311 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01713855
(ClinicalTrials.gov)		October 200418/10/2012Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic PurpuraVaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)Idiopathic Thrombocytopenic Purpura;Immune Thrombocytopenic PurpuraBiological: Inactivated Trivalent Influenza vaccineNeufeld, Ellis J, MD, PhDTerrana ITP Research FundCompleted18 Months18 YearsBoth10N/AUnited States